Are you a patient or carer?

This information is intended solely for patients who have been prescribed a Chiesi product by a UK healthcare professional, and their carers. Please confirm below, or go back to the home page.

UK-RES-2101605 August 2021

You are now leaving Chiesi's website

By clicking this link, you will be taken to a website that is not owned or controlled by Chiesi. Chiesi is not responsible for the content provided on that site.

Go back

UK-RES-2101574 August 2021

Select Page

What is Trimbow® NEXThaler® 88/5/9?

Trimbow NEXThaler 88/5/9 comes in an inhaler known as a dry powder inhaler (DPI). This type of inhaler may or may not be familiar to you; the resources section below includes a user guide, which can help you to use your Trimbow NEXThaler 88/5/9 properly.

Trimbow NEXThaler 88/5/9 contains three medicines in one inhaler:

  • beclometasone
  • formoterol
  • glycopyrronium

Beclometasone belongs to a group of medicines called corticosteroids, which help to reduce the swelling and irritation in the lungs.

Formoterol, a long-acting beta-agonist, and glycopyrronium, a long-acting muscarinic antagonist, are medicines that relax the muscles in the airways, helping to open them wider and allowing you to breathe more easily.

Helpful resources

Trimbow® User Guide - Download Button - PDF: 0.92mb
Patient Information Leaflet - Download Button - PDF: 0.59mb
This website has been provided by Chiesi Limited to support patients, and carers of patients, prescribed Chiesi respiratory products. If you have not been prescribed Trimbow NEXThaler 88/5/9 and are looking for information on another Chiesi respiratory product please visit our homepage.

The information provided here is not intended to replace the advice of your healthcare professional. If you have any questions about your medication, please speak to your doctor, nurse or pharmacist.

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

Trimbow® NEXThaler® 88/5/9 user guide:

Watch ‘how to’ use your Trimbow device without a spacer
How to use your inhaler

How to use your inhaler with an AeroChamber® plus spacer